NIH Director Jay Bhattacharya highlights national biomedical priorities in address at the University of Florida
National Institutes of Health Director Jay Bhattacharya, M.D., Ph.D., shared his vision for biomedical research in the U.S. during a visit to the University of Florida on March 11, highlighting the impact of new technologies, long-standing challenges and reforms he views as critical to restoring public trust in science and accelerating biomedical progress.
Speaking to hundreds of UF faculty, students and staff, Bhattacharya discussed the impact of chronic diseases, the need to economically scale treatment advances and support for the broader research community nationally as scientists seek to advance human health through basic and translational research.
He described specific reforms he hopes to pursue that will enable the pursuit of bold, high-risk ideas, empower early career scientists to pursue transformative work, reinforce confidence in science, modernize research replication practices and broaden participation nationwide, enabling breakthrough discoveries to emerge from a wider array of universities.
“Together, these reforms strengthen rigor and accelerate discovery, positioning the nation’s biomedical enterprise to address its most urgent health challenges,” Bhattacharya said.
The speech came at the end of a day of briefings organized in collaboration with U.S. Rep. Kat Cammack.
“Each year, UF researchers compete for and win hundreds of millions in support from the National Institutes of Health, advancing discoveries that strengthen our economy, improve public health and keep America leading the world in science,” Cammack said. “Through our work on the House Energy and Commerce Committee, I’m focused on ensuring institutions like UF have the support and policy framework needed to continue leading these efforts.”
During the presentations, UF scientists demonstrated how the university leverages its comprehensive, interdisciplinary expertise to advance research in areas like drug discovery, cancer immunotherapy and translational neuroscience. They also touched on how UF’s artificial intelligence prowess strengthens all of its research.
“The biomedical ecosystem UF has developed allows our scientists to discover, test, build and deliver solutions at the speed and size needed to serve our large, diverse state,” said UF Vice President for Research David Norton. “It was an honor to share with Dr. Bhattacharya and Representative Cammack how this approach can serve as a model for the nation.”
UF presented Bhattacharya with a comprehensive look at its most advanced biomedical research initiatives, showing how the university is building an integrated pipeline that moves discoveries toward real-world patient impact.
“Dr. Bhattacharya’s visit underscores the extraordinary momentum of biomedical discovery happening here at the University of Florida,” said Jennifer Hunt, M.D., M.Ed., interim dean of the UF College of Medicine and the Folke H. Peterson Dean's Distinguished Professor. “We are committed to translating bold ideas into meaningful advances for patients, and it is energizing to see UF’s interdisciplinary strengths — from AI-driven health research to pioneering work in cancer, neuroscience and chronic disease — recognized at the national level, reaffirming that UF is not only contributing to the future of biomedical science but helping to shape it.”
During the briefings, UF faculty highlighted drug discovery and biomedical innovation, artificial intelligence in human health, cancer research that include UF Health’s NCI designated cancer institute, and recent breakthroughs in mRNA cancer vaccine development. They also discussed chronic disease and neurodegenerative research, including advances related to aging, Alzheimer’s disease, Parkinson’s disease, stroke and translational interventions moving toward clinical care.
As part of a demonstration about digital twins, Bhattacharya, a self-described gamer, donned immersive goggles and quizzed a virtual doctor in a virtual UF hospital room about a hypothetical surgery.
Throughout the presentations and discussions with researchers, Bhattacharya praised UF for its outstanding work, saying he was impressed with the depth and innovation, particularly UF’s embrace of artificial intelligence. Within this context, Bhattacharya praised UF’s OneFlorida+ Clinical Research Network, which leverages more than 30 million deidentified medical records from Florida and five other states to create unique virtual clinical trials and train artificial intelligence models using UF’s HiPerGator supercomputer.
“Our researchers conveyed a unified vision of a university drawing together world-class science, computation and clinical partnerships to accelerate breakthroughs from bench to bedside — and ultimately into the highest standard of care across Florida and beyond,” said Interim UF President Donald Landry.